Details

Autor(en) / Beteiligte

• Demoor, Magali
• Ollitrault, David
• Gomez-Leduc, Tangni
• Bouyoucef, Mouloud
• Hervieu, Magalie
• Fabre, Hugo
• Lafont, Jérôme
• Denoix, Jean-Marie
• Audigié, Fabrice
• Mallein-Gerin, Frédéric
• Legendre, Florence
• Galera, Philippe

Titel

Cartilage tissue engineering: Molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction

Ist Teil von

• Biochimica et biophysica acta, 2014-08, Vol.1840 (8), p.2414-2440

Ort / Verlag

Netherlands: Elsevier B.V

Erscheinungsjahr

2014

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Articular cartilage defects are a veritable therapeutic problem because therapeutic options are very scarce. Due to the poor self-regeneration capacity of cartilage, minor cartilage defects often lead to osteoarthritis. Several surgical strategies have been developed to repair damaged cartilage. Autologous chondrocyte implantation (ACI) gives encouraging results, but this cell-based therapy involves a step of chondrocyte expansion in a monolayer, which results in the loss in the differentiated phenotype. Thus, despite improvement in the quality of life for patients, reconstructed cartilage is in fact fibrocartilage. Successful ACI, according to the particular physiology of chondrocytes in vitro, requires active and phenotypically stabilized chondrocytes. This review describes the unique physiology of cartilage, with the factors involved in its formation, stabilization and degradation. Then, we focus on some of the most recent advances in cell therapy and tissue engineering that open up interesting perspectives for maintaining or obtaining the chondrogenic character of cells in order to treat cartilage lesions. Current research involves the use of chondrocytes or progenitor stem cells, associated with “smart” biomaterials and growth factors. Other influential factors, such as cell sources, oxygen pressure and mechanical strain are considered, as are recent developments in gene therapy to control the chondrocyte differentiation/dedifferentiation process. This review provides new information on the mechanisms regulating the state of differentiation of chondrocytes and the chondrogenesis of mesenchymal stem cells that will lead to the development of new restorative cell therapy approaches in humans. This article is part of a Special Issue entitled Matrix-mediated cell behaviour and properties. •3D culture, hypoxia and chondrogenic factors enhance chondrocyte (re-)differentiation.•Stem cells seem to be good candidates for cartilage engineering.•Knowledge of molecular mechanisms is a prerequisite for cartilage engineering.•The development of new “smart” biomaterials remains an essential objective.•Clinical trials are possible but some concerns must be bypassed.